Eden tirzepatide review
Advertised at $199, billed at $298. Position 11 of 18 on our board.
Updated 2026-09-18
DISCLOSURE — Coreage Rx pays this desk a commission when a reader signs up through our link. It buys no ranking, no score and no deletions. Method: how we rate. Full terms: disclosure.
Eden advertises $199. Eden bills about $298 from month two. The $99 in between is a membership that renews after a $39 introductory period.
This is the single clearest advertised-versus-billed gap on our tirzepatide board, and it is entirely legal — the terms say so. It is simply not what the landing page leads with, and it is the number that decides your year.
The numbers
| Eden · tirzepatide | |
|---|---|
| Advertised | $199/mo |
| Membership | $99/mo |
| Billed | $298/mo |
| Advertised-to-billed gap | +$99/mo |
| Per year | $3,576 |
| Board position | 11 of 18, cheapest first |
The $199 medication price is real, but the $99/month membership renews alongside it.
Where the gap is
$99 a month, arriving in month two, worth about $1,188 a year. To Eden’s credit the medication price itself is flat across published dose ranges, so climbing the ladder does not add anything further.
Against the board
About $3,576 a year puts Eden in the upper half of the board, above Mochi at $3,336 — which includes an insurance team Eden does not provide.
| Programme | Advertised | Billed | Gap | Vs board floor |
|---|---|---|---|---|
| Coreage Rx | $149 | $199 | +$50 | +$74/mo |
| Trimi | $125 | $125 | none | — |
| Ozari Health | $125 | $125 | none | — |
| Fifty 410 | $133 | $133 | none | +$8/mo |
| PlexusDx | $129 | $189 | +$60 | +$64/mo |
| Ivím Health | $199 | $199 | none | +$74/mo |
| Zealthy | $216 | $216 | none | +$91/mo |
| Hims & Hers | $199 | $238 | +$39 | +$113/mo |
How the programme works
Compounded GLP-1 marketplace that advertises low medication prices and bills a separate recurring membership.
Verified facts
- Compounded semaglutide advertised at $99/month.
- Compounded tirzepatide advertised at $199/month.
- Membership is $39 as an introductory rate, then $99/month ongoing.
- True ongoing cost for tirzepatide lands near $298/month once membership is included.
Checked 2026-09-18. This market re-prices without notice — anything older than a month is a starting point, not a quote.
For it
- Genuinely low medication-only pricing.
- Fast onboarding with flat rates across published dose ranges.
Against it
- The membership renews at $99/month after the $39 introductory period.
- Advertised prices exclude the fee that most affects the yearly total.
Read this bit. The $99 semaglutide headline becomes roughly $198/month once the membership renews at its ongoing rate.
Score
3.1 out of 5 on our rubric, which is fixed before assessment and published on how we rate.
| Criterion | Weight | Score |
|---|---|---|
| True monthly cost | 30% | 3.1 / 5 |
| Price honesty | 20% | 2.6 / 5 |
| Clinical support | 20% | 3.3 / 5 |
| Pharmacy sourcing | 15% | 3.4 / 5 |
| Cancelling | 15% | 3.1 / 5 |
Verdict
Sound product, misleading shop window. If you were going to pay $298 anyway, Mochi gives you more for it.
More from the desk
- Coreage Rx tirzepatide review
Advertised at $149, billed at $199. Position 1 of 18 on our board.
- Trimi tirzepatide review
Advertised at $125 and billed at $125 — no gap. Position 2 of 18 on our board.
- Ozari Health tirzepatide review
Advertised at $125 and billed at $125 — no gap. Position 3 of 18 on our board.
- Cheapest right now
Every programme sorted on what it bills, not what it advertises. Floor: $199/mo tirzepatide, $149/mo semaglutide.
- Six fee traps
Every advertised-to-billed gap on our board comes from one of these six structures. Learn them and you can read any of these sites in ninety seconds.
- Where the traps are
The biggest advertised-to-billed gaps on our board, and the programmes charging most for the same category of medication.